The rare neurological disease treatment market study by Fact.MR offers compelling insights into key growth drivers and restraints impacting the market through 2028.
North America to Account for 40% of the Global Rare Neurological Disease Treatment Market
The rare neurological disease treatment market study by Fact.MR offers compelling insights into key growth drivers and restraints impacting the market through 2028. The survey offers rare neurological disease treatment demand outlook and studies opportunities existing in key segments, including drug class and route of administration. It also highlights key strategies adopted by market players to increase rare neurological disease treatment sales.
Fact.MR – A Market Research and Competitive Intelligence Provider: Between 2018 and 2028, the global rare neurological disease treatment market is expected to increase at an impressive CAGR of over 8.5%, growing 2.3 times.
The incidence of rare diseases, the evolving trend of orphan pharmaceuticals, and rising healthcare spending have all contributed to a significant increase in overall sales of rare neurological treatments during the previous decade. Also, rapid developments in the healthcare sector are pushing demand for rare neurological disease treatments.
The injectable route of administration is gaining popularity and is expected to reach US$ 8.1 billion between 2021 and 2031. The market for injectables will expand tremendously in the future years, according to Fact.MR due to strong demand for patient-friendly parenteral drug delivery methods and an increasing number of surgical treatments.
Get Sample Copy With Impact Analysis Of COVID-19 Of Market Report
https://www.factmr.com/connectus/sample?flag=S&rep_id=4594
Aside from these, manufacturers are concentrating their efforts on research & development in order to produce novel therapies that would improve patient care. Key industry players such as Novartis AG, Pfizer Inc., and Johnson & Johnson Services, Inc. are predicted to possess more than 50% of the global market, according to Fact.MR.
Due to factors such as increased investments in research and development operations, as well as a focus on expanding healthcare infrastructure, the North American market is expected to grow rapidly.
“Strategic partnerships between pharmaceutical giants and researchers as well as orphan drug legislations are providing financial incentives for companies developing drugs for rare neurological diseases”, Says an Analyst at Fact.MR
Key Takeaways:
- North America controls 40% of the global market for rare neurological disease treatments in terms of revenue.
- Three countries in East Asia, including Japan, Taiwan, and South Korea, have implemented policies to promote orphan drug research and development. As a result, the region is predicted to increase at a rate of over 8% during the projection period (2018-2028).
- The robust expansion of the worldwide rare neurological disease treatment market is being fueled by rising per capita healthcare spending on rare neurological disorders such as Alzheimer’s.
- During the projected period, healthcare spending on Alzheimer’s disease treatment is expected to generate an absolute dollar opportunity of more than $5 billion.
- The retail pharmacy and drug store industry continues to establish high standards for customer satisfaction and is expected to increase at a 9% Y-o-Y rate over the projection period.
Growth Drivers:
- The market is growing as the prevalence of rare neurological illnesses rises.
- As the focus shifts to orphan drugs for the treatment of rare neurological diseases, chances for growth will emerge.
Key Restraints
- Expensive treatment cost of rare neurological disease is expected to hamper the market growth.
To learn more about Rare Neurological Disease Treatment Market, you can get in touch with our Analyst at:
https://www.factmr.com/connectus/sample?flag=AE&rep_id=4594
Competitive Landscape
Rare neurological disease treatment manufacturers are undertaking strategic partnerships and acquisitions to gain an edge over other competitors.
For instance, in 2020, Biogen Inc announced the acquisition of a novel CNS-penetrant small molecule inhibitor of casein kinase 1 (CK 1), for the potential treatment of patients with behavioural and neurological systems across various neurological and psychiatric diseases from Pfizer Inc.
Some of the leading players operating in the rare neurological disease treatment market profiled by Fact.MR are:
- Novartis AG
- Pfizer, Inc.
- Johnson & Johnson Services, Inc.
- Bayer AG
- GlaxoSmithKline Plc
- Sanofi S.A.
- Allergan Plc
- Merck & Co., Inc.
More Valuable Insights on Rare Neurological Disease Treatment Market
Fact.MR, in its new report, offers an unbiased analysis of the global rare neurological disease treatment market, analyzing forecast statistics through 2018 and beyond. the survey reveals growth projections on rare neurological disease treatment market with detailed segmentation:
Drug Class
- Anti-depressants
- Anti-psychotics
- Cholinesterase Inhibitors
- Biologics
- Others (Anti-vertigo, Anti-seizure, etc.)
Route of Administration
- Injectable
- Oral
Disease Indication
- Alzheimer’s Diseases
- Narcolepsy
- Multiple Sclerosis
- Amyotrophic Lateral Sclerosis
- Others
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies and Drug Store
- Online Pharmacies
Region
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
Key Questions Covered in the Rare Neurological Disease Treatment Market Report
- The market survey also highlights projected sales growth for rare neurological disease treatment market between 2018 and 2028
- The report offers insight into rare neurological disease treatment demand outlook for forecast period 2018-2028
- Rare neurological disease treatment market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, collaborations or partnerships, and others
- Rare neurological disease treatment market analysis identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
Explore Fact.MR’s Coverage on the Healthcare Domain –
Rare Neurodegenerative Disease Treatment Market Forecast - In the long run, the rise in medical tourism and investments in modernizing healthcare infrastructure across Asia Pacific’s developing countries are projected to benefit the rare neurodegenerative disease treatment market. Long-term growth will be aided by advances in medical technology for the diagnosis and treatment of various ailments.
Neuro Critical Care Market Analysis - A significant factor driving the growth of the neuro critical care market over the projected period is expected to be increasing advances in neurosurgery methods as a result of the growing requirement for neuro critical care. Another important driving force in the sector is the rising prevalence of brain tumors.
Neurointerventional Devices Market Growth - The global neurointerventional devices market is predicted to develop at a healthy rate in terms of revenue. For neurointerventional treatment, healthcare professionals in ambulatory surgical centers and hospitals favor minimally invasive techniques.
Cancer Biomarkers Market Scope - Governments’ aggressive funding initiatives for cancer diagnostics are expanding the market for cancer biomarkers. Demand for cancer biomarkers will be bolstered by factors such as the availability of low-cost, non-invasive prognosis.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR